Clinical Trial

A Study of JMT203 in Patients With Cancer Cachexia

Name: A Study of JMT203 in Patients With Cancer Cachexia — clinical trial record (NCT06868849)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

A Phase Ia/II, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of JMT203 in Patients with Cancer Cachexia

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-09.

Trial Details

NCT Number	NCT06868849
Lead Sponsor	Shanghai JMT-Bio Inc.
Conditions	Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia, Colorectal Cancer Cachexia, Pancreatic Cancer Cachexia
Enrollment	307 participants
Start Date	2024-05-15
Primary Completion	2027-08-14 (estimated)
Study Completion	2029-05-15 (estimated)
Updated on ClinicalTrials.gov	2026-05-22